SEC Form 25-NSE filed

1/26/21 10:07:15 AM ET

$ARA

Misc Health and Biotechnology Services

Health Care

Get the next $ARA alert in real time by email

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

UNITED STATES

OMB APPROVAL

OMB Number:		3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:		1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-37751

Issuer:	American Renal Associates Holdings, Inc.
Exchange:	NEW YORK STOCK EXCHANGE LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	500 Cummings Center, Suite 6550
	Beverly	MASSACHUSETTS	01915
Telephone number:				(978) 922-3080

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Common Stock

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, NEW YORK STOCK EXCHANGE LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2021-01-26	By	Victoria Paper		Lead Analyst, Regulation
Date		Name		Title

¹	Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $ARA alert in real time by email

SEC Form 25-NSE filed

1/26/21 10:07:15 AM ET

$ARA

Misc Health and Biotechnology Services

Health Care

Get the next $ARA alert in real time by email

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

UNITED STATES

OMB APPROVAL

OMB Number:		3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:		1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-37751

Issuer:	American Renal Associates Holdings, Inc.
Exchange:	NEW YORK STOCK EXCHANGE LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	500 Cummings Center, Suite 6550
	Beverly	MASSACHUSETTS	01915
Telephone number:				(978) 922-3080

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Common Stock

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

2021-01-26	By	Victoria Paper		Lead Analyst, Regulation
Date		Name		Title

¹	Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $ARA alert in real time by email

SEC Form 25-NSE filed

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$ARA

SEC Form 25-NSE filed

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$ARA

$ARA
Press Releases

American Renal Associates Completes Transaction With Innovative Renal Care, a Nautic Partners Portfolio Company

$ARA
SEC Filings

SEC Form 15-12B filed

SEC Form EFFECT filed

SEC Form SC 13G/A filed

$ARA
Insider Trading

SEC Form 4 filed by P L Partners Capital Centerbridge

SEC Form 4: W Thomas Erickson disposed to the issuer $0 worth of Common Stock (67,755 units at $0.00), decreasing ownership by 100% to 0 units

SEC Form 4: J Christopher Hocevar disposed to the issuer $0 worth of Common Stock (18,679 units at $0.00), decreasing ownership by 100% to 0 units

SEC Form 25-NSE filed

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $ARA

SEC Form 25-NSE filed

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $ARA

$ARA Press Releases

American Renal Associates Completes Transaction With Innovative Renal Care, a Nautic Partners Portfolio Company

$ARA SEC Filings

SEC Form 15-12B filed

SEC Form EFFECT filed

SEC Form SC 13G/A filed

$ARA Insider Trading

SEC Form 4 filed by P L Partners Capital Centerbridge

SEC Form 4: W Thomas Erickson disposed to the issuer $0 worth of Common Stock (67,755 units at $0.00), decreasing ownership by 100% to 0 units

SEC Form 4: J Christopher Hocevar disposed to the issuer $0 worth of Common Stock (18,679 units at $0.00), decreasing ownership by 100% to 0 units

Recent Analyst Ratings for
$ARA

Recent Analyst Ratings for
$ARA

$ARA
Press Releases

$ARA
SEC Filings

$ARA
Insider Trading